Takeda Pharmaceutical Co. and Daiichi Sankyo Co. are each considering producing vaccines for new and seasonal influenza, a move that would likely increase sharply supplies of domestically produced vaccines, sources close to the matter said Monday.
via Kyodo News – Story.